Scott Randal W.
SEC insider (Form 3/4/5 filer). CIK 0001337801. Director at Freenome, Inc. (FRNM) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in PALO ALTO, CA.
Companies Scott Randal W. has filed insider reports for
- Freenome, Inc. (FRNM): Director
- BridgeBio Pharma, Inc. (BBIO): Director
Scott Randal W.
CIK: 0001337801
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 15, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect6.2K shares at avg. $66.69$413K - May 15, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect2.1K shares at avg. $67.53$141K - May 15, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect1.5K shares at avg. $68.23$103K - May 15, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect200 shares at avg. $69.12$14K - May 15, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect10K shares at avg. $16.75$168K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect1.9K shares at avg. $74.34$141K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect4.8K shares at avg. $75.57$362K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect10K shares at avg. $16.75$168K - Feb 17, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect3.3K shares at avg. $75.93$251K - Nov 17, 2025BBIO
BridgeBio Pharma, Inc.
ExerciseDirect10K shares at avg. $16.75$168K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 |  BBIO BridgeBio Pharma, Inc. | Sale | 6,200 | $66.69 | $413,464 | Direct |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 2,088 | $67.53 | $141,003 | Direct |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 1,512 | $68.23 | $103,164 | Direct |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 200 | $69.12 | $13,824 | Direct |
| May 15, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 10,000 | $16.75 | $167,500 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 1,900 | $74.34 | $141,250 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 4,793 | $75.57 | $362,219 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 10,000 | $16.75 | $167,500 | Direct |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 3,307 | $75.93 | $251,088 | Direct |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc. | Exercise | 10,000 | $16.75 | $167,500 | Direct |
1-10 of 13 transactions